INTC vs STRO
Intel Corporation (INTC) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Intel Corporation (INTC) is a semiconductors company listed on US. It is led by Pat Gelsinger.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported INTC revenue for 2025-12-27 was $52.85B. Net income was -$267.0M. Revenue was down 0.5% from 2024-12-28 to 2025-12-27. INTC currently screens at market cap $498.43B.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
INTC currently screens at market cap $498.43B. STRO currently screens at market cap $470.8M.
Not investment advice. Open the INTC and STRO stock pages for the full models.
Not investment advice.